Financials
- Market Capitalization 2.24 M
- Employee 2
- Founded 2013
- CEO N/A
- Website www.matinasbiopharma.com
- Headquarter Delaware, United States
- FIGI BBG005WX2XG8
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-0.29
市销率
86.7
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 5075 | OGEN Oragenics Inc. Common Stock | 0.57 USD | -3.39% | -1.72% | -8.06% | -10.02% | 2.57 M USD | ||
| 5083 | CLDI Calidi Biotherapeutics, Inc. Common Stock | 0.12 USD | -7.69% | -14.29% | -25.00% | -84.12% | 2.32 M USD | ||
| 5090 | PHGE BiomX Inc. COmmon Stock | 0.22 USD | 0.00% | -15.38% | -60.71% | -95.90% | 2.23 M USD | ||
| 5092 | VRAX Virax Biolabs Group Limited - Ordinary Shares | 3.74 USD | -8.11% | +23.84% | +2237.50% | +325.00% | 2.17 M USD |